Adjuvant radiotherapy in Stage I endometrial cancer. Where do we stand?

This paper reviews the anatomical spread and failure patterns of surgical Stage I endometrial cancer. The controversial aspects of the optimal adjuvant treatment are presented. An attempt is made to identify the most effective management approach based on the pertinent literature data.

Stage I endometrial cancer; Risk factors; Lymphadenectomy; Adjuvant radiotherapy

[1] Winter R.: "Gynaecologic malignancies: pattern of spread". CME J Gynecol. Oneal., 2000, 5 (2), 100.

[2] Creasman W.T., Morrow C.P., Bundy B.N. et al.: "Surgical pathologic spread patterns of endometrial cancer". Cancer, 1987, 60, 2035.

[3] Morrow C.P., Bundy B.N., Kurman R.J. et al.: "Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynaecologic oncology group study". Gynecol. Oneal., 1991, 40, 55.

[4] Chuang L., Burke T.W., Tornos C. et al.: "Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes". Gynecol. Oneal., 1995, 58, 189.

[5] Mohan D.S., Samuels M.A., Selim M.A. et al.: "Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I. endometrial adenocarcinoma". Gynecol. Oneal., 1998, 70, 165.

[6] Yokoyama Y., Maruyama H., Sato S. et al.: "Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers" Gynecol. Oneal., 1997, 64, 411.

[7] Mariani A., Webb M.J., Keeney G.L. et al.: "Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer". Gynecol. Oneal., 2001, 81, 100.

[8] Benedetti-Panici P., Maneschi F., Cutillo G. et al.: "Anatomical and pathological study of retroperitoneal nodes in endometrial cancer." Int. J. Gynecol. Cancer, 1998, 8, 322.

[9] Benedetti-Panici P., Maneschi F., Scambia G. et al.: "Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and paraaortic lymphadenectomy". Gynecol. Oneal., 1996, 62, 19.

[10] Podratz K.C., Mariani A., Webb M.J.: "Staging and therapeutic value of lymphadenectomy in endometrial cancer. Editorial". Gynecol. Oneal., 1998, 70, 163.

[11] Fanning D.O.: "Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy". Gynecol. Oneal., 2001, 82, 371.

[12] Larson D.M., Broste S.K., Krawisz B.R.: "Surgery without radiotherapy for primary treatment of endometrial cancer". Obstet. Gynecol., 1998, 91, 355

[13] Orr J.W., Holimon J.L., Orr P.F.: "Stage I corpus cancer: is teletherapy necessary?". Am. J. Obstet. Gynecol., 1997, 176, 777.

[14] Petereit D.G.: "Complete surgical staging in endometrial cancer provides prognostic information only". Sem. in Rad. Oneal., 2000, 1, 8.

[15] Naumann R.W., Higgins R.Y., Hall J.B.: "The use of adjuvant radiation therapy in endometrial cancer by members of the Society of Gynecologic Oncologists (SGO)". Gynecol. Oneal., 1999, 72, 448.

[16] Maggi no T., Romagnolo C,. Zola P. et al.: "An analysis of approaches to the treatment of endometrial cancer in Western Europe: a CTF study". Eur]. of Cancer, 1995, 31A 12, 1993.

[17] Creutzberg C.L., Putten W.L.J., Koper P.C.M. et al.: "Surgery and postoperative radiotherapy versus surgery alone for patients with Stage l endometrial carcinoma: multicentre randomised trial". Lancet, 2000, 355, 1404.

[18] Roberts J.A., Brunetto V.L., Keys H.M. et al.: "A phase III randomised study of surgery vs. surgery plus adjuvant radiation therapy in intermediate risk endometrial adenocarcinoma. Abstract". Gynecol. Oneal., 1998, 68, 135.

[19] Onsrud M., Kolstad P., Normann T.: "Postoperative external pelvic irradiation in carcinoma of the corpus Stage I: a controlled chnical trial". Gynecol. Oneal., 1976, 4, 222.

[20] Chadha M.: "Gynecologic brachytherapy-II: Intravaginal brachytherapy for carcinoma of the endometrium". Sem. in Rad. Oncol., 2002, 12, 53.

[21] Anderson J.M., Stea B., Hallum A.Y. et al.: "High-dose-rate postoperative vaginal cuff irradiation alone for Stage IB and IC endometrial cancer". Int. J. Radiat. Oneal. Biol. Phys., 2000, 46, 417.

[22] Ng T.Y., Perrin L.C., Nicklin J.L. et al.: "Local recurrence in high-risk node-negative Stage I. endometrial carcinoma treated with postoperative vaginal vault brachytherapy". Gynecol. Oneal., 2000, 79, 490.

[23] Horowitz N.S., Peters W.A., Smith M.R. et al.: "Adjuvant high dose rate vaginal brachytherapy as treatment of Stage I. and IL endometrial carcinoma". Obstet. Gynecol., 2002, 99, 235.

[24] Alektiar K.M., McKee A., Venkatraman E. et al.: "Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade I and 2) endometrial cancer". Int. J. Radiat. Oneal. Biol. Phys., 2002, 53, 707.

[25] Eltabakh G.H., Piver M.S., Hemp ling R.E. et al.: "Excellent long-term survival and absence of vaginal recurrences in 303 patients with low-risk Stage I. endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial". Int. J. Radiat. Oneal. Biol. Phys., 1997, 38, 373.

[26] Burger M.P.: "Management of Stage I. endometrial carcinoma". BMJ, 2001, 322, 568.

[27] Greven K.M.: "Tailoring radiation to the extent of the disease for uterine-confined endometrial cancer". Sem. in Rad. Oneal., 2000, I, 29.